Page last updated: 2024-11-08

thymidine 5'-4-nitrophenyl phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thymidine 5'-4-nitrophenyl phosphate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

p-nitrophenyl thymidine 5'-monophosphate : A pyrimidine 2'-deoxyribonucleoside 5'-monophosphate that is the mono-p-nitrophenyl ester of thymidine 5'-monophosphate. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID164953
CHEMBL ID596169
CHEBI ID74144
SCHEMBL ID8428624
MeSH IDM0101613

Synonyms (28)

Synonym
3'-thymidylic acid, mono(4-nitrophenyl) ester
thymidine 3'-phosphate 4-nitrophenyl ester
4-nitrophenyl 3'-thymidylate
16562-50-8
pnppt
CHEMBL596169
p-nitrophenyl thymidinyl phosphate
chebi:74144 ,
[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl (4-nitrophenyl) hydrogen phosphate
2304-08-7
5'-thymidylic acid, mono(4-nitrophenyl) ester
thymidine 5'-4-nitrophenyl phosphate
thymidine 5'-monophosphate p-nitrophenyl ester
thymidine-5'-p-nitrophenyl phosphate
dtmp mono-p-nitrophenyl ester
thymidine 5'-monophosphate 4-nitrophenyl ester
p-nitrophenyl thymidylate
4-nitrophenyl thymidylate
4-nitrophenyl thymidine 5'-monophosphate
5'-o-[hydroxy(4-nitrophenoxy)phosphoryl]-thymidine
pnp-tmp
p-nitrophenyl thymidine 5'-monophosphate
thymidine-p-nitrophenyl phosphate
SCHEMBL8428624
Q27144457
1-{2-deoxy-5-o-[hydroxy(4-nitrophenoxy)phosphoryl]pentofuranosyl}-4-hydroxy-5-methylpyrimidin-2(1h)-one
DTXSID10937116
5'-o-[(s)-hydroxy(4-nitrophenoxy)phosphoryl]thymidine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
pyrimidine 2'-deoxyribonucleoside 5'-monophosphate
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
aryl phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (9)

Processvia Protein(s)Taxonomy
immune system process5'-3' exonuclease PLD3Homo sapiens (human)
DNA metabolic process5'-3' exonuclease PLD3Homo sapiens (human)
inflammatory response5'-3' exonuclease PLD3Homo sapiens (human)
myotube differentiation5'-3' exonuclease PLD3Homo sapiens (human)
regulation of cytokine production involved in inflammatory response5'-3' exonuclease PLD3Homo sapiens (human)
phagocytosis5'-3' exonuclease PLD4Homo sapiens (human)
DNA metabolic process5'-3' exonuclease PLD4Homo sapiens (human)
inflammatory response5'-3' exonuclease PLD4Homo sapiens (human)
innate immune response5'-3' exonuclease PLD4Homo sapiens (human)
establishment of localization in cell5'-3' exonuclease PLD4Homo sapiens (human)
regulation of cytokine production involved in inflammatory response5'-3' exonuclease PLD4Homo sapiens (human)
phagocytosis5'-3' exonuclease PLD4Homo sapiens (human)
hematopoietic progenitor cell differentiation5'-3' exonuclease PLD4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
phospholipase D activity5'-3' exonuclease PLD3Homo sapiens (human)
protein binding5'-3' exonuclease PLD3Homo sapiens (human)
single-stranded DNA 5'-3' DNA exonuclease activity5'-3' exonuclease PLD3Homo sapiens (human)
phospholipase D activity5'-3' exonuclease PLD4Homo sapiens (human)
single-stranded DNA 5'-3' DNA exonuclease activity5'-3' exonuclease PLD4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
Golgi membrane5'-3' exonuclease PLD3Homo sapiens (human)
lysosomal membrane5'-3' exonuclease PLD3Homo sapiens (human)
endoplasmic reticulum membrane5'-3' exonuclease PLD3Homo sapiens (human)
early endosome membrane5'-3' exonuclease PLD3Homo sapiens (human)
late endosome membrane5'-3' exonuclease PLD3Homo sapiens (human)
lysosomal lumen5'-3' exonuclease PLD3Homo sapiens (human)
extracellular exosome5'-3' exonuclease PLD3Homo sapiens (human)
early endosome5'-3' exonuclease PLD4Homo sapiens (human)
endoplasmic reticulum membrane5'-3' exonuclease PLD4Homo sapiens (human)
trans-Golgi network membrane5'-3' exonuclease PLD4Homo sapiens (human)
nucleus5'-3' exonuclease PLD4Homo sapiens (human)
phagocytic vesicle5'-3' exonuclease PLD4Homo sapiens (human)
nucleus5'-3' exonuclease PLD4Homo sapiens (human)
endoplasmic reticulum5'-3' exonuclease PLD4Homo sapiens (human)
phagocytic vesicle5'-3' exonuclease PLD4Homo sapiens (human)
trans-Golgi network membrane5'-3' exonuclease PLD4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1768559Substrate activity at PLD4 (unknown origin) assessed as Km by Michaelis-Menten kinetic model based fluorescence assay2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Modulators of immunoregulatory exonucleases PLD3 and PLD4 identified by high-throughput screen.
AID451305Half life in total cell extract of deoxynucleoside analogue-sensitive mouse L1210 cells by HPLC analysis in presence of snake venom phosphodiesterase2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Special feature of mixed phosphotriester derivatives of cytarabine.
AID1768561Substrate activity at PLD4 (unknown origin) assessed as Kcat by Michaelis-Menten kinetic model based fluorescence assay2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Modulators of immunoregulatory exonucleases PLD3 and PLD4 identified by high-throughput screen.
AID1768563Substrate activity at PLD4 (unknown origin) assessed as ratio of Kcat to Km by Michaelis-Menten kinetic model based fluorescence assay2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Modulators of immunoregulatory exonucleases PLD3 and PLD4 identified by high-throughput screen.
AID1768558Substrate activity at PLD3 (unknown origin) assessed as Km by Michaelis-Menten kinetic model based fluorescence assay2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Modulators of immunoregulatory exonucleases PLD3 and PLD4 identified by high-throughput screen.
AID451306Half life in total cell extract of nucleoside analogue-resistant mouse L1210 10K cells by HPLC analysis in presence of snake venom phosphodiesterase2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Special feature of mixed phosphotriester derivatives of cytarabine.
AID1768562Substrate activity at PLD3 (unknown origin) assessed as ratio of Kcat to Km by Michaelis-Menten kinetic model based fluorescence assay2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Modulators of immunoregulatory exonucleases PLD3 and PLD4 identified by high-throughput screen.
AID1768560Substrate activity at PLD3 (unknown origin) assessed as Kcat by Michaelis-Menten kinetic model based fluorescence assay2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Modulators of immunoregulatory exonucleases PLD3 and PLD4 identified by high-throughput screen.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.76)18.7374
1990's1 (5.88)18.2507
2000's10 (58.82)29.6817
2010's3 (17.65)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.51 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index5.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]